Publications by authors named "Aaron Michael Rulseh"
Introduction: Glioblastoma (GBM) is the most common malignant primary brain tumor, and methods to improve the early detection of disease progression and evaluate treatment response are highly desirable. We therefore explored changes in whole-brain apparent diffusion coefficient (ADC) values with respect to survival (progression-free [PFS], overall [OS]) in a cohort of GBM patients followed at regular intervals until disease progression.
Methods: A total of 43 subjects met inclusion criteria and were analyzed retrospectively.
Diffusion tensor imaging in the characterization of multiple system atrophy.
Neuropsychiatr Dis Treat
September 2016
Purpose: Multiple system atrophy (MSA) is a rare neurodegenerative disease that remains poorly understood, and the diagnosis of MSA continues to be challenging. We endeavored to improve the diagnostic process and understanding of in vivo characteristics of MSA by diffusion tensor imaging (DTI).
Materials And Methods: Twenty MSA subjects, ten parkinsonian dominant (MSA-P), ten cerebellar dominant (MSA-C), and 20 healthy volunteer subjects were recruited.
Article Synopsis
- Glioblastoma multiforme (GBM) is a serious brain tumor that usually only gives patients about 10 to 14 months to live, and most patients don't survive longer than three years.
- A new treatment called Tumor-treating fields (TTField) uses special electric fields to help kill the cancer cells and has been approved for treating a tough version of GBM called recurrent GBM (RGBM).
- In a small study, some patients who received TTField therapy are now healthy and have been cancer-free for over seven years, which is really promising!